Antibodies against human Toll-like receptors (TLRs): TLR distribution and localization in human dendritic cells

Abstract

We have produced monoclonal antibodies (mAbs) against human Toll-like receptors (TLRs). These mAbs recognize the natural conformation of the extracellular domain leucine-rich repeats and, thereby, are suitable for immunoprecipitation, flow cytometric analysis and immunostaining. Using these mAbs, we determined the distribution of TLRs in a variety of human cell populations. Human TLRs that recognize bacterial components, particularly TLR-1, TLR-2, TLR-4 and TLR-6, reside on the cell surface and are expressed in myeloid and monocyte-derived dendritic cells (DCs) but not in plasmacytoid DCs (pDCs). Human TLR-3 resides in putative endosomes in myeloid DCs. Thus, the human myeloid DC subset harbors a unique and distinctive TLR repertoire. These mAbs will be useful to test the localization and distribution of human TLRs in a variety of cells and organs. Functional studies of human TLRs will also be feasible since certain of them are function-blocking mAbs.

Keywords

Monoclonal antibodies human TLRs TLR distribution TLR localization human dendritic cells

References

Janeway Jr CA , Medzhitov R. Innate immune recognition. Annu Rev Immunol 2002; 20: 197—216.

Seya T. , Akazawa T. , Uehori J. , Matsumoto M. , Azuma I. , Toyoshima K. Role of Toll-like receptors and their adapters in adjuvant immunotherapy for cancer. Anticancer Res 2003; 23: 4369—4376.

Takeda K. , Kaisho T. , Akira S. Toll-like receptors. Annu Rev Immunol 2003 ; 21: 335—376.

Honda K. , Yanai H. , Negishi H. et al. IRF-7 is the master regulator of type-I interferon-dependent immune responses. Nature 2005; 434: 772—777.

Takaoka A. , Yanai H. , Kondo S. et al. Integral role of IRF-5 in the gene induction programme activated by Toll-like receptors. Nature 2005; 434: 243—249.

Kawai T. , Sato S. , Ishii KJ et al. Interferon-alpha induction through Toll-like receptors involves a direct interaction of IRF7 with MyD88 and TRAF6. Nat Immunol 2004; 5: 1061—1068.

Seya T. , Oshiumi H. , Akazawa T. , Matsumoto M. TICAM-1 and TICAM-2: Toll-like receptor adapters that participate in induction of type 1 interferons. Int J Biochem Cell Biol 2005; 37: 524—529.

Matsumoto M. , Kikkawa S. , Kohase M. , Miyake K. , Seya T. Establishment of a monoclonal antibody against human Toll-like receptor 3 that blocks double-stranded RNA-mediated signaling . Biochem Biophys Res Commun 2002; 293: 1364—1369.

Uehori J. , Matsumoto M. , Tsuji S. et al. Simultaneous blocking of human Toll-like receptor 2 and 4 suppresses myeloid dendritic cell activation induced by Mycobacterium bovis bacillus Calmette-Guérin (BCG)-peptidoglycan (PGN). Infect Immun 2003; 71: 4238—4249.

10.

Matsumoto M. , Funami K. , Tanabe M. et al. Subcellular localization of human Toll-like receptor 3 in human dendritic cells. J Immunol 2003; 171: 3154—3162.

11.

Nakao T. , Nishiguchi M. , Kikkawa S. et al. Cell surface expression of human Toll-like receptor 6 participates in the recognition of diacylated-lipopeptide and peptidoglycan: tested by mAbs. J Immunol 2005; 174: 1566—1573.

12.

Seya T. , Matsumoto M. , Akazawa T. , Toyoshima K. Differential maturation of dendritic cells by TLR adapters: application to immunotherapy. In: Toyoshima K, Barrett JC, Klein E, Hashimoto Y, Wakasugi H. (eds) Cancer Immunotherapy. Princess Takamatsu Cancer Research Fund, Princess Takamatsu Symposia 2004; 34: 12—15.

13.

Seya T. , Akazawa T. , Tsujita T. , Matsumoto M. Role of Toll-like receptors in adjuvant-augmented vaccine therapy. eCAM 2005; In press.

14.

Tapping RI , Akashi S. , Miyake K. , Godowski PJ , Tobias PS Toll-like receptor 4, but not Toll-like receptor 2, is a signaling receptor for Escherichia and Salmonella lipopolysaccharides. J Immunol 2000; 165: 5780—5787.

15.

Tsujita T. , Tsukada H. , Nakao M. , Oshiumi H. , Matsumoto M. , Seya T. Sensing bacterial flagellin by membrane and soluble orthologs of Toll-like receptor 5 in rainbow trout (Onchorhynchus mikiss). J Biol Chem 2004; 279: 48588—48597.

16.

Inoue N. , Fukui A. , Nomura M. , Matsumoto M. , Toyoshima K. , Seya T. A novel chicken membrane-associated complement-regulatory protein: molecular cloning and functional characterization of a chicken membrane SCR protein . J Immunol 2001; 166: 424—-431.

17.

Sasai M. , Matsumoto M. , Oshiumi H. , Seya T. The TICAM-1 pathway in the Toll-like receptor signaling. J Biochem (Tokyo) 2005; In press.

18.

Funami K. , Matsumoto M. , Oshiumi H. , Akazawa T. , Yamamoto A. , Seya T. Multifunctional feature of Toll-like receptor 3 cytoplasmic tail that regulates receptor localization and signaling. Int Immunol 2004; 16: 1143—1154.

19.

Iwasaki A. , Medzhitov R. Toll-like receptor control of the adaptive immune responses. Nat Immunol 2004; 10: 987—994.

20.

Underhill DM , Ozinsky A. Toll-like receptors: key mediators of microbe detection. Curr Opin Immunol 2002; 14: 103—110.

21.

Takeda K. , Takeuchi O. , Akira S. Recognition of lipopeptides by Toll-like receptors. J Endotoxin Res 2002; 8: 459—463.

22.

O'Neill LA After the Toll rush. Science 2004; 303: 1481—1482.

23.

Nishiya T. , DeFranco AL. Ligand-regulated chimeric receptor approach reveals distinctive subcellular localization and signaling properties of the Toll-like receptors . J Biol Chem 2004; 279: 19008—19017.

24.

Akira S. , Takeda K. Functions of toll-like receptors: lessons from KO mice. Compte Rendue Biol 2004; 327: 581—589.

25.

Latz E. , Schoenemeyer A. , Visintin A. et al. TLR-9 signals after translocating from the ER to CpG DNA in the lysosome. Nat Immunol 2004; 5:190-198.

26.

Schulz O. , Diebold SS , Chen M. et al. Toll-like receptor 3 promotes cross-priming to virus-infected cells . Nature 2005; 433: 887—892.

27.

Yoneyama M. , Kikuchi M. , Natsukawa T. et al. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat Immunol 2004; 5: 730—737.

28.

Andrejeva J. , Childs KS , Young DF et al. The V proteins of paramyxoviruses bind the IFN-inducible RNA helicase, mda-5, and inhibit its activation of the IFN-beta promoter. Proc Natl Acad Sci USA 2004; 101: 17264—17269.

29.

Honda K. , Ohba Y. , Yanai H. et al. Spatiotemporal regulation of MyD88—IRF-7 signalling for robust type-I interferon induction. Nature 2005; 434: 1035—1040.

30.

Kubo T. , Hatton RD , Oliver J. , Liu X. , Elson CO , Weaver CT Regulatory T cell suppression and anergy are differentially regulated by proinflammatory cytokines produced by TLRactivated dendritic cells. J Immunol 2004; 173: 7249—7258.

31.

Janeway Jr CA , Travers P. , Walport M. , Shlomchik M. Immunobiology V. New York : Garland, 2001; 35—91.

32.

Seya T. , Matsumoto M. , Tsuji S. et al. Two receptor theory in innate immune activation: studies on the receptors for bacillus Calmat Guillen-cell wall skeleton (BCG-CWS). Arch Immunol Ther Exp 2001; 49 (Suppl. ): 13—21.

33.

Diebold SS , Kaisho T. , Hemmi H. , Akira S. , Reis e Sousa C. Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science 2004; 303: 1529—1531.